Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Xuyong Zhao"'
Publikováno v:
Heliyon, Vol 10, Iss 10, Pp e31473- (2024)
Background: Globally, cardiovascular disease (CVD) has emerged as a leading cause of mortality. Bisphenol A (BPA), recognized as one of the most prevalent and widely distributed endocrine-disrupting chemicals (EDCs), has been consistently linked to t
Externí odkaz:
https://doaj.org/article/49871ae05e444a2d87ffd496ae1afc1d
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 15, Iss 1, Pp 1-12 (2023)
Abstract Background Heart failure is closely correlated with diabetic cardiomyopathy (DCM) and can lead to mortality. Celastrol has long been utilized for the treatment of immune and inflammatory disorders. However, whether celastrol would exert prot
Externí odkaz:
https://doaj.org/article/f218c789509e4d3bbcda39fa428941fa
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
ObjectiveDiabetic cardiomyopathy (DCM), characterized by cardiomyopathy with the absence of coronary artery disease, hypertension, and valvular heart disease in patients with diabetes, significantly increases the risk of heart failure. Galectin-3 (Ga
Externí odkaz:
https://doaj.org/article/fa496fd3456543a0a4848326956abdd6
Publikováno v:
BMC Cardiovascular Disorders, Vol 18, Iss 1, Pp 1-8 (2018)
Abstract Background Free fatty acids (FFAs) predicted the risk of heart failure (HF) and were elevated in HF with very low left ventricular ejection fraction (LVEF) compared to healthy subjects. The aim of this study was to investigate whether total
Externí odkaz:
https://doaj.org/article/c283a4a50c434698b8300ae26d2249b8
Publikováno v:
2022 41st Chinese Control Conference (CCC).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::daa86c113a730df378557ec7145a4a51
https://doi.org/10.23919/ccc55666.2022.9902849
https://doi.org/10.23919/ccc55666.2022.9902849
Publikováno v:
Evidence-Based Complementary and Alternative Medicine, Vol 2020 (2020)
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-based Complementary and Alternative Medicine : eCAM
Background. Aloperine is an active component of Sophora alopecuroides Linn, which has been extensively applied for the treatment of cardiovascular disease (CVD). However, our current understanding of the molecular mechanisms supporting the effects of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::219bf3b676f395b88488b5395263d11f
https://doaj.org/article/a2fb80206b2f4b9bb9ac0171f240ee1e
https://doaj.org/article/a2fb80206b2f4b9bb9ac0171f240ee1e
Publikováno v:
BMC Cardiovascular Disorders, Vol 18, Iss 1, Pp 1-8 (2018)
BMC Cardiovascular Disorders
BMC Cardiovascular Disorders
Background Free fatty acids (FFAs) predicted the risk of heart failure (HF) and were elevated in HF with very low left ventricular ejection fraction (LVEF) compared to healthy subjects. The aim of this study was to investigate whether total levels of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc0064464d7c7cf9713394f332495248
http://link.springer.com/article/10.1186/s12872-018-0850-0
http://link.springer.com/article/10.1186/s12872-018-0850-0
Publikováno v:
Biomedicine & Pharmacotherapy. 97:551-556
Ischemia and reperfusion(I/R) injury can cause complications in applying blood flow treatment for atherosclerosis occlusion syndrome. Platelet activation and inflammatory reaction play a role in the procession of I/R injury. This study was designed t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e40e7af1bd768290f972a34161de9f12
https://doi.org/10.1016/j.biopha.2017.10.094
https://doi.org/10.1016/j.biopha.2017.10.094
Publikováno v:
BioMed Research International, Vol 2017 (2017)
Schisandrin B (ScB), isolated from Schisandra chinensis (S. chinensis), is a traditional Chinese medicine with proven cardioprotective and neuroprotective effects. However, it is unclear whether ScB also has beneficial effects on rat hind limb ischem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a31ffbc566e4badbbb679b4f0f997a94
https://doi.org/10.1155/2017/4237973
https://doi.org/10.1155/2017/4237973
Publikováno v:
Medicine
Left atrial (LA) remodeling has been identified to predict atrial fibrillation (AF) and heart failure. However, the role of LA diameter (LAD) in patients with heart failure (HF) with preserved (HFpEF), mid-range (HFmrEF), and reduced ejection fractio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45a105b708b63dd3a49dbc80316b42dd
https://pubmed.ncbi.nlm.nih.gov/31770253
https://pubmed.ncbi.nlm.nih.gov/31770253